RightFit Trial Directory

Lung Cancer clinical trials in Charleston, SC

15 recruiting lung cancer studies with a site in Charleston, SC.

All trials in Charleston, SC · All Lung Cancer trials

RecruitingPhase 3NCT03394365

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Sponsor: Pierre Fabre Medicament

Charleston, SC · +39 more sites

RecruitingPhase 3NCT04267848

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Sponsor: National Cancer Institute (NCI)

Bluffton, SC · Boiling Springs, SC · Charleston, SC · +1147 more sites

RecruitingPhase 1NCT06179069

A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

Sponsor: Zai Lab (Shanghai) Co., Ltd.

Charleston, SC · +10 more sites

RecruitingPhase 2NCT06031688

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Sponsor: SWOG Cancer Research Network

Anderson, SC · Charleston, SC · +276 more sites

RecruitingPhase 3NCT06119581

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Sponsor: Eli Lilly and Company

Charleston, SC · Greenville, SC · West Columbia, SC · +84 more sites

RecruitingNot applicableNCT07177846

LiveWell: An Adapted Dialectical Behavioral Therapy Skills Training Protocol for Patients Living With Metastatic Lung Cancer

Sponsor: Medical University of South Carolina

Charleston, SC

RecruitingNot applicableNCT06070870

Health Education Approach to Lung Screening

Sponsor: Virginia Commonwealth University

Charleston, SC · +2 more sites

RecruitingPhase 2NCT07098988

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

Sponsor: CatalYm GmbH

Charleston, SC · +6 more sites

RecruitingNot applicableNCT06538636

Prediction Augmented Screening Initiative

Sponsor: VA Office of Research and Development

Charleston, SC · +3 more sites

RecruitingPhase 2NCT05642572

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Sponsor: SWOG Cancer Research Network

Anderson, SC · Bluffton, SC · Boiling Springs, SC · +451 more sites

RecruitingPhase 2 / Phase 3NCT03851445

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Sponsor: SWOG Cancer Research Network

Anderson, SC · Bluffton, SC · Boiling Springs, SC · +1226 more sites

RecruitingPhase 2NCT06424067

Phase 2 Study of Fingolimod in Lung Cancers

Sponsor: Medical University of South Carolina

Charleston, SC

RecruitingPhase not listedNCT05236114

GEMINI-NSCLC: NSCLC Biomarker Study

Sponsor: Tempus AI

Charleston, SC · +57 more sites

RecruitingPhase 1 / Phase 2NCT05914116

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Sponsor: DualityBio Inc.

Charleston, SC · Greenville, SC · +26 more sites

Not yet recruitingPhase 2NCT07720167

Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer

Sponsor: Medical University of South Carolina

Charleston, SC

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.